In summary, our data indicate that USP53 inhibits the inactivation of the NF‐κB pathway by reducing the ubiquitination of IκBα to further inhibit ccRCC proliferation and metastasis. This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.